Literature DB >> 33691623

Improvement of analgesic efficacy for total hip arthroplasty by a modified ultrasound-guided supra-inguinal fascia iliaca compartment block.

Ting Zheng1,2, Bin Hu2, Chun-Ying Zheng1,2, Feng-Yi Huang1,2, Fei Gao1,2, Xiao-Chun Zheng3,4,5.   

Abstract

BACKGROUND: Fascia iliaca compartment block (FICB) is an anterior approach to the lumbar plexus block and provides the effective adjunctive analgesia for total hip arthroplasty (THA).
METHODS: As a case series study, 28 patients (≥ 65 years old) with THA were received a modified in-plane ultrasound-guided supra-inguinal (S-FICB) as an analgesic adjunct to evaluate the analgesic effectiveness and the local anesthetic diffusion with magnetic resonance imaging (MRI). A combination of propofol and sufentanil was administered to conduct target-controlled infusion.
RESULTS: The pain scores were 1 (0-4), 2 (1-5), 3 (1-6) and 3 (1-6) at 4, 8, 12, and 24 h. The cumulative opioids were 8 (8-12), 18 (16-32), 28 (24-54) and 66 (48-104) mg of i.v. morphine equivalents at 4, 8, 12, and 24 h. The patient-controlled analgesia (PCA) times were 0 (0-1), 1 (0-2), 2 (0-5) and 5 (3-8) at 4, 8, 12, and 24 h. In lateral, anterior and medial part of thigh, the sensory blockade in 28 patients was 23 (82 %), 21 (75 %) and 19 (68 %) at 5 min; 28 (100 %) at 10 and 20 min. Motor blockade of femoral nerve (FN) and obturator nerve (ON) was present in 13 (46 %) and 3 (11 %) patients at 5 min, 24 (86 %) and 9 (32 %) at 10 min, 26 (93 %) and 11 (39 %) at 20 min. Injectate permeated to the FN and extended superiorly over the surface of iliac muscle (IM) and pectineus muscle (PM) in all patients.
CONCLUSIONS: The modified S-FICB has provided an effective postoperative analgesic adjunct after THA with the satisfactory blockade of femoral (FN), obturator (ON) and sciatic (SN) nerves, especially for ON, when compared with the existing techniques.

Entities:  

Keywords:  Compartment block technique; Fascia iliaca; In‐plane ultrasound‐guided; Lumbar plexus block; Magnetic resonance imaging concentrates

Mesh:

Year:  2021        PMID: 33691623      PMCID: PMC7944595          DOI: 10.1186/s12871-021-01296-8

Source DB:  PubMed          Journal:  BMC Anesthesiol        ISSN: 1471-2253            Impact factor:   2.217


  3 in total

1.  Ultrasound guided fascia iliaca block: a comparison with the loss of resistance technique.

Authors:  John Dolan; Anne Williams; Eileen Murney; Malcolm Smith; Gavin N C Kenny
Journal:  Reg Anesth Pain Med       Date:  2008 Nov-Dec       Impact factor: 6.288

2.  Analgesic Efficacy of Ultrasound Guided FICB in Patients with Hip Fracture.

Authors:  Devender Kumar; Sarla Hooda; Shashi Kiran; Jyoti Devi
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  Comparison of the fascia iliaca compartment block with the 3-in-1 block in children.

Authors:  B Dalens; G Vanneuville; A Tanguy
Journal:  Anesth Analg       Date:  1989-12       Impact factor: 5.108

  3 in total
  3 in total

1.  Applicability and effectiveness of ultrasound combined with nerve stimulator-guided lumbosacral plexus block in the supine versus lateral position during surgeries for lower limb fracture-a prospective randomized controlled trial.

Authors:  Yuting Xu; Jie Song; Xiaoqiong Xia; Xianwen Hu; Yawen Li; Yongbo Yu; Liang Wang; Zhiguo Tao
Journal:  BMC Anesthesiol       Date:  2022-06-03       Impact factor: 2.376

2.  Correction to: Improvement of analgesic efficacy for total hip arthroplasty by a modified ultrasound-guided supra-inguinal fascia iliaca compartment block.

Authors:  Ting Zheng; Bin Hu; Chun-Ying Zheng; Feng-Yi Huang; Fei Gao; Xiao-Chun Zheng
Journal:  BMC Anesthesiol       Date:  2021-03-31       Impact factor: 2.217

3.  Ultrasound-guided supra-inguinal fascia Iliaca compartment block for older adults admitted to the emergency department with hip fracture: a randomized controlled, double-blind clinical trial.

Authors:  Liang Chen; Yang Shen; Shuangmei Liu; Yanyan Cao; Zhe Zhu
Journal:  BMC Geriatr       Date:  2021-12-01       Impact factor: 3.921

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.